Publications
653
Citations
39,252
Est. group size
~9
Recurring co-author estimate
Active years
47
Publishing since 1980
Brad H. Rovin's research focuses on kidney diseases caused by immune system dysfunction, especially lupus nephritis (kidney inflammation from lupus) and IgA nephropathy. His work includes leading and analyzing large clinical trials of new drugs (such as belimumab, obinutuzumab, and voclosporin), studying biomarkers that predict how kidneys respond to treatment, and helping develop clinical practice guidelines used by doctors worldwide. Prospective students would likely engage with clinical trial data, kidney biopsy studies, and biomarker research aimed at improving treatment for autoimmune kidney conditions.
Publication output has grown steadily over the last decade, rising from about 15 papers per year in 2017 to over 60 per year in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PO:11:273 CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, for active SLE with inadequate response to glucocorticoids and at least 2 immunosuppressants: a phase 2 trial in progress
2026
- Authors' Reply: Convergent Proteinuria Reduction across Distinct Therapeutic Pathways in IgA Nephropathy
Clinical Journal of the American Society of Nephrology · 2026
- Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis
Kidney International · 2026
- Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
New England Journal of Medicine · 2025
- KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Kidney International · 2025
- 2024 American College of Rheumatology (<scp>ACR</scp>) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Arthritis & Rheumatology · 2025
- Treatment of patients with IgA nephropathy: a call for a new paradigm
Kidney International · 2025
- KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children
Kidney International · 2025
- 2024 American College of Rheumatology (<scp>ACR</scp>) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Arthritis Care & Research · 2025
- Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Kidney International · 2025
- Lupus nephritis
Nature Reviews Disease Primers · 2025
- Lupus nephritis trials network (LNTN) repeat kidney biopsy-based definitions of treatment response: A systematic literature review-based proposal
Autoimmunity Reviews · 2025
- Effect of Long‐Term Voclosporin Treatment on Renal Histology in Patients With Active Lupus Nephritis With Repeat Renal Biopsies
Arthritis & Rheumatology · 2025
- Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop
Kidney International · 2025
- Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children
Kidney International · 2025
- Journal of the American Society of Nephrology×79
- Kidney International×74
- Kidney International Reports×57
- Annals of the Rheumatic Diseases×28
- Nephrology Dialysis Transplantation×21
- Isabelle Ayoub
Medicine · The Ohio State University
- Samir V. Parikh
Medicine · The Ohio State University
- Mahmoud Kallash
Medicine · The Ohio State University
- Jorge Rojas-Rivera
Medicine · The Ohio State University
- Salem Almaani
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile